Medtronic (MDT) Cash from Investing Activities (2014 - 2026)

Medtronic's Cash from Investing Activities history runs 13 years deep, the most recent figure standing at -$816.0 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 3.2% year-over-year to -$816.0 million; the TTM figure through Jan 2026 stood at -$2.5 billion (down 16.99% YoY), while the FY2025 annual figure was -$1.9 billion, up 18.13% from the prior year.
• Cash from Investing Activities came in at -$816.0 million for Q1 2026 at Medtronic, down from -$482.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $271.0 million in Q2 2022 to a low of -$1.6 billion in Q3 2022.
• A 5-year average of -$587.0 million and a median of -$490.0 million in 2025 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities soared 84.24% in 2022 and sank 275.28% in 2023, its largest moves.
• Medtronic's Cash from Investing Activities stood at -$1.1 billion in 2022, then soared by 63.0% to -$424.0 million in 2023, then rose by 18.63% to -$345.0 million in 2024, then slumped by 39.71% to -$482.0 million in 2025, then tumbled by 69.29% to -$816.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$816.0 million, -$482.0 million, and -$719.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison